Cross-linking porcine pericardium by 3, 4-dihydroxybenzaldehyde: a novel method to improve the biocompatibility of bioprosthetic valve
B Wu, C Zheng, K Ding, X Huang, M Li… - …, 2020 - ACS Publications
Heart valve replacement is an effective therapy for patients with moderate to severe valvular
stenosis or regurgitation. Most bioprosthetic heart valves applied clinically are based on …
stenosis or regurgitation. Most bioprosthetic heart valves applied clinically are based on …
Cross-Linking Porcine Pericardium by 3, 4-Dihydroxybenzaldehyde: A Novel Method to Improve the Biocompatibility of Bioprosthetic Valve
B Wu, C Zheng, K Ding, X Huang, M Li, S Zhang… - Biomacromolecules, 2021 - Elsevier
Heart valve replacement is an effective therapy for patients with moderate to severe valvular
stenosis or regurgitation. Most bioprosthetic heart valves applied clinically are based on …
stenosis or regurgitation. Most bioprosthetic heart valves applied clinically are based on …
Cross-Linking Porcine Pericardium by 3, 4-Dihydroxybenzaldehyde: A Novel Method to Improve the Biocompatibility of Bioprosthetic Valve
B Wu, C Zheng, K Ding, X Huang, M Li… - …, 2021 - pubmed.ncbi.nlm.nih.gov
Heart valve replacement is an effective therapy for patients with moderate to severe valvular
stenosis or regurgitation. Most bioprosthetic heart valves applied clinically are based on …
stenosis or regurgitation. Most bioprosthetic heart valves applied clinically are based on …
Cross-Linking Porcine Pericardium by 3, 4-Dihydroxybenzaldehyde: A Novel Method to Improve the Biocompatibility of Bioprosthetic Valve.
B Wu, C Zheng, K Ding, X Huang, M Li, S Zhang… - …, 2020 - europepmc.org
Heart valve replacement is an effective therapy for patients with moderate to severe valvular
stenosis or regurgitation. Most bioprosthetic heart valves applied clinically are based on …
stenosis or regurgitation. Most bioprosthetic heart valves applied clinically are based on …